Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.BACKGROUND

FDA adverse event reporting system
Using FDA Adverse Events Reporting System reports from January 1, 2005 to December 31, 2015, we calculated pharmacovigilance signal measures (i.e., reporting odds ratio, proportional reporting ratio, information component, and empirical Bayes geometric mean) for abuse-related adverse event (AR-AE)-gabapentin pairs. 
FDA Adverse Events Reporting System